Inventor

TRENTMANN STEFAN

DE9 patents

⚠️ This page may combine multiple inventors who share the name “TRENTMANN STEFAN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

PIERIS PHARMACEUTICALS GMBH

5 patents

US9687524B2Jun 27, 2017

Tear lipocalin muteins binding IL-4 R alpha

PIERIS PHARMACEUTICALS GMBH6 citations81

US9610356B2Apr 4, 2017

Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation

PIERIS PHARMACEUTICALS GMBH7 citations79

US9950034B2Apr 24, 2018

Methods for preventing or treating disorders by increasing bioavailability of iron and related pharmaceutical formulation

PIERIS PHARMACEUTICALS GMBH3 citations71

US10232014B2Mar 19, 2019

Tear lipocalin muteins binding IL-4 R alpha

PIERIS PHARMACEUTICALS GMBH3 citations70

US9751920B2Sep 5, 2017

Muteins with tear lipocalin having affinity to human c-met receptor tyrosine kinase and methods for obtaining the same

PIERIS PHARMACEUTICALS GMBH0 citations51

TRENTMANN STEFAN

1 patent

US9051382B2Jun 9, 2015

Human neutrophil gelatinase-associated lipocalin (hNGAL) muteins that bind hepcidin and nucleic acid encoding such

TRENTMANN STEFAN26 citations87

HOHLBAUM ANDREAS

1 patent

US8986951B2Mar 24, 2015

Tear lipocalin in muteins binding IL-4 R alpha

HOHLBAUM ANDREAS13 citations86

MATSCHINER GABRIELE

1 patent

US9212208B2Dec 15, 2015

Muteins with tear lipocalin having affinity to human c-Met receptor tyrosine kinase and methods for obtaining the same

MATSCHINER GABRIELE6 citations82

ASTRAZENECA AB

1 patent

US10898545B2Jan 26, 2021

Tear lipocalin muteins binding IL-4 r alpha

ASTRAZENECA AB2 citations70